Abstract Details
| David Uzenot, MD (Service de Neurologie et de Pathologie Neurom) | No disclosure on file |
| Hussam Shaker, MD (C&RMEP) | No disclosure on file |
| Jean Pouget, MD, PhD (CHU La Timone) | No disclosure on file |
| Jerome Franques, MD | No disclosure on file |
| Annie Verschueren (Genzyme) | No disclosure on file |
| Jean P. Azulay, MD | Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. |
| No disclosure on file | |
| Alyana Samai | No disclosure on file |
| Shahram Attarian, MD, PhD (CHU La Timone Aix Marseille University) | Prof. Attarian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI, Pfizer LFB, Alnylam Biogen Argenx, UCB Alexion, Astrazenica, Amicus, Janssen, Novartis, Roche. Prof. Attarian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SANOFI, Biogen,Alnylam, Argenix, USB, Alexion Astrazenica, Janssen, Roche. The institution of Prof. Attarian has received research support from National Institut of Health . |